LVW Advisors LLC purchased a new stake in The Clorox Company (NYSE:CLX – Free Report) in the first quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor purchased 1,610 shares of the company’s stock, valued at approximately $247,000.
A number of other institutional investors and hedge funds have also recently added to or reduced their stakes in CLX. Choreo LLC boosted its holdings in shares of Clorox by 12.8% in the fourth quarter. Choreo LLC now owns 5,741 shares of the company’s stock valued at $819,000 after acquiring an additional 652 shares during the period. abrdn plc boosted its holdings in shares of Clorox by 20.1% in the fourth quarter. abrdn plc now owns 198,250 shares of the company’s stock valued at $28,268,000 after acquiring an additional 33,135 shares during the period. Savoir Faire Capital Management L.P. boosted its holdings in shares of Clorox by 61.8% in the fourth quarter. Savoir Faire Capital Management L.P. now owns 65,192 shares of the company’s stock valued at $9,296,000 after acquiring an additional 24,897 shares during the period. Game Plan Financial Advisors LLC acquired a new stake in shares of Clorox in the first quarter valued at approximately $1,025,000. Finally, Banque Cantonale Vaudoise boosted its holdings in shares of Clorox by 78.2% in the first quarter. Banque Cantonale Vaudoise now owns 29,335 shares of the company’s stock valued at $4,492,000 after acquiring an additional 12,872 shares during the period. 78.53% of the stock is owned by institutional investors and hedge funds.
Clorox Trading Down 0.1 %
Clorox stock opened at $136.47 on Monday. The stock has a market cap of $16.95 billion, a PE ratio of 70.71, a P/E/G ratio of 2.19 and a beta of 0.39. The stock has a 50-day moving average price of $136.95 and a 200 day moving average price of $143.79. The Clorox Company has a 52 week low of $114.68 and a 52 week high of $169.14. The company has a current ratio of 0.90, a quick ratio of 0.53 and a debt-to-equity ratio of 9.73.
Analysts Set New Price Targets
Several equities research analysts have recently weighed in on the company. Deutsche Bank Aktiengesellschaft decreased their price objective on Clorox from $155.00 to $151.00 and set a “hold” rating for the company in a report on Wednesday, April 17th. Citigroup cut their price objective on Clorox from $155.00 to $150.00 and set a “neutral” rating for the company in a research report on Wednesday, May 1st. Evercore ISI cut their price objective on Clorox from $145.00 to $142.00 and set an “underperform” rating for the company in a research report on Wednesday, May 1st. BNP Paribas initiated coverage on Clorox in a research report on Monday, June 24th. They issued an “underperform” rating and a $130.00 price objective for the company. Finally, UBS Group cut their price objective on Clorox from $164.00 to $159.00 and set a “neutral” rating for the company in a research report on Wednesday, May 1st. Five research analysts have rated the stock with a sell rating and fourteen have assigned a hold rating to the company. Based on data from MarketBeat, the stock currently has a consensus rating of “Hold” and a consensus target price of $145.33.
Read Our Latest Research Report on Clorox
Clorox Company Profile
The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.
Read More
- Five stocks we like better than Clorox
- REIT Stocks – Best REIT Stocks to Add to Your Portfolio Today
- 3 Stocks Upgraded by Analysts: Home Depot, U.S. Steel, Alcoa
- Canadian Penny Stocks: Can They Make You Rich?
- NVIDIA and TSM Stock: Is Semiconductor Sector Momentum Slowing?
- Are These Liquid Natural Gas Stocks Ready For An Upside Bounce?
- Palo Alto Networks Stock Gains AI-Powered Cybersecurity Solutions
Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Clorox Company (NYSE:CLX – Free Report).
Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.